Skip to main content

Table 3 Multivariate analyses of factors related with PD in advanced NSCLC

From: Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

Variables

β

S.E.

Wald

df

Sig.

OR

95% CI for OR

Score

Lower

Upper

NMPs, ≥160 events/μL

1.321

0.604

4.779

1

0.029

3.748

1.147

12.253

4

PMPs, ≥80 events/μL

2.395

0.666

12.930

1

<0.0001

10.968

2.973

40.462

11

NLR, ≥3.3

1.595

0.613

6.779

1

0.009

4.929

1.483

16.375

5

Constant

−3.607

0.767

22.123

1

0.000

0.027

   
  1. NMPs neutrophil-derived microparticals, PMPs platelet-derived microparticles, NLR neutrophil-lymphocyte ratio, CYFRA-211 Cytokeratin 19 fragment